Skip to main content
Premium Trial:

Request an Annual Quote

Cloudy, With a Chance of (Data) Showers

The $1,000 genome won't do any good for science if researchers can't interpret it, says Adina Mangubat, CEO of Spiral Genetics, in Xconomy. While industry has focused most of its time and energy to creating better ways to sequence a genome, it has "largely ignored the computational power required to extract and analyze the genomic data in a timeframe that keeps it relevant," Mangubat adds. And most labs aren't prepared for all that data. Many have said the solution to this is, at least in part, cloud computing. "Unfortunately, as many researchers have discovered, the cloud is not as welcoming as its white fluffy exterior suggests," she says.

The real solution will only come when the industry shares best practices, collaborates to find the best direction to spend money in, "and supports continued aggressive development of bioinformatics software that works in a cloud environment," Mangubat says. "Without industry support and bioinformatics technology allowing for analysis in a day, lab managers, researchers and sequencing instrument companies are running headlong into a data disaster."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.